(e-mail: ).Ĭystic renal cell carcinoma (RCC) is almost certainly overdiagnosed and overtreated. From the Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (S.G.S., A.B.S.) Disease-Focused Panel on Renal Cell Carcinoma, Society of Abdominal Radiology, Houston, Tex (S.G.S., I.P., N.M.H., N.S., A.D.S., E.M.R., A.B.S., N.E.C., S.S.R., S.A.W., S.D.K., Z.J.W., H.C., M.S.D.) Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (I.P.) Departments of Radiology and Urology, Michigan Medicine, University of Michigan, 1500 E Medical Center Dr, B2-A209A, Ann Arbor, MI 48109 (J.H.E., N.E.C., S.D.K., M.S.D.) Department of Radiology, New York University Langone Medical Center, New York, NY (N.M.H., H.C.) Department of Radiology, University of Ottawa, Ottawa, Canada (N.S.) Department of Radiology, University of Alabama School of Medicine, Birmingham, Ala (A.D.S.) Imaging Institute and Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio (E.M.R.) Department of Radiology, David Geffen School of Medicine, UCLA Center for the Health Sciences, Los Angeles, Calif (S.S.R.) Department of Radiology, University of Wisconsin Hospital and Clinics, Madison, Wis (S.A.W.) and Department of Radiology, UCSF Medical Center, San Francisco, Calif (Z.J.W.).
